An integrated research roadmap for MED is proposed that prioritizes biomarker-enriched cohorts, combination vascular and neurodegenerative therapies, and pragmatic trials, and offers the most plausible strategy to reduce the growing global burden of MED.
Adam de Havenon, Kevin N. Sheth, Carolyn A. Fredericks et al.· Neurotherapeutics· 0 citations
The current clinical evidence base is reviewed, including the role of LF-MRI in supporting stroke-type classification and tissue confirmation, in wake-up and unknown-onset stroke for tissue-based triage, and in post-therapeutic settings to enable serial assessment after thrombolysis or thrombectomy.
A. Sorby-Adams, N. Pintér, Keith W. Muir et al.· Stroke· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.